The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden - Analysis of variations by region over the period 1991-2010

Clinical Kidney Journal

Volumn 6, Issue 3, 2013, Pages 352-357

  Qureshi, Abdul Rashid ^a   Evans, Marie ^a   Stendahl, Maria ^b   Prütz, Karl Göran ^c   Elinder, Carl Gustaf ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

^d STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

dialysis; geography; kidney disease; survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; SEX DIFFERENCE; SWEDEN;

EID: 84878525137     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sft032     Document Type: Article

References (37)

1. Levey AS, Andreoli SP, DuBose T et al. Chronic kidney disease: common, harmful and treatable-World Kidney Day 2007. Am J Nephrol 2007; 27: 108-112
2. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14: 31-41
3. Stewart JH, McCredie MR, Williams SM et al. The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002. Am J Kidney Dis 2006; 48: 183-191
4. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis 2006; 47: 445-454
5. Collins AJ, Foley RN, Herzog C et al. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010; 55: S1-420, A6-A7
6. Rippe B. Aktiv uremivård i Sverige 1991-2010. En demografisk översikt. http://www.medscinet.net/snr/rapporterdocs/Årsrapport %202011.pdf. (2 February 2011, date last accessed).
7. Cass A, Cunningham J, Wang Z et al. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001; 175: 24-27
8. Foxman B, Moulton LH, Wolfe RA et al. Geographic variation in the incidence of treated end-stage renal disease. J Am Soc Nephrol 1991; 2: 1144-1152
9. Rosansky SJ, Huntsberger TL, Jackson K et al. Comparative incidence rates of end-stage renal disease treatment by state. Am J Nephrol 1990; 10: 198-204
10. Usami T, Koyama K, Takeuchi O et al. Regional variations in the incidence of end-stage renal failure in Japan. JAMA 2000; 284: 2622-2624
11. Usami T, Sato R, Yoshida A et al. Regional variation in endstage renal disease. Curr Opin Nephrol Hypertens 2002; 11: 343-346
12. Wimmer F, Oberaigner W, Kramar R et al. Regional variability in the incidence of end-stage renal disease: an epidemiolo-gical approach. Nephrol Dial Transplant 2003; 18: 1562-1567
13. Wikstrom B, Fored M, Eichleay MA et al. The financing and organization of medical care for patients with end-stage renal disease in Sweden. Int J Health Care Finance Econ 2007; 7: 269-281
14. K/DOQI clinical practice guidelines on hypertension and anti-hypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43:S1-290
15. European best practice guidelines. Nephrol Dial Transplant 2002; 17: 7-15
16. Schön S, Ekberg H, Wikstrom B et al. Renal replacement therapy in Sweden. Scand J Urol Nephrol 2004; 38: 332-339
17. Schön S, Wikstrom B, Ekberg H et al. Aktiv uremivård i Sverige 1991-2005. In: Jönköping: Svenskt Njurregister 2006; 28.
18. Bray F. Age-standardization. In: Parkin D, Whelan S, Ferlay J, (eds). Cancer incidence in five continents. Lyon, France: International Agency for Research on Cancer, 2002.
19. van de Luijtgaarden MWM, Noordzij M, Wanner C et al. Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report. Clin Kidney J 2012; 5: 109-119
20. Čala S. Decreasing trends in incidence and prevalence of renal replacement therapy in Croatia from 2000 to 2009. Clin Kidney J 2012; 5: 309-314
21. Evans M, Tettamanti G, Nyrén O et al. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med 2011; 269: 289-298
22. Turner JM, Bauer C, Abramowitz MK et al. Treatment of chronic kidney disease. Kidney Int 2012; 81: 351-362
23. Couchoud C, Guihenneuc C, Bayer F et al. The timing of dialysis initiation affects the incidence of renal replacement therapy. Nephrol Dial Transplant 2010; 25: 1576-1578
24. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57: A8, e1-526
25. Stel VS, Kramer A, Zoccali C et al. The 2006 ERA-EDTA Registry annual report: a precis. J Nephrol 2009; 22: 1-12
26. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; 26: 2604-2610
27. Hommel K, Rasmussen S, Madsen M et al. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2010; 25: 947-951
28. Gilg J, Webb L, Feest T et al. UK Renal Registry 13th Annual Report (December 2010): chapter 9: haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2009: national and centre-specific analyses. Nephron Clin Pract 2011; 119: c149-c177
29. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007; 18: 2644-2648
30. Jager KJ, van Dijk PC. Has the rise in the incidence of renal replacement therapy in developed countries come to an end? Nephrol Dial Transplant 2007; 22: 678-680
31. Visser A, Noordzij M, Gansevoort RT et al. Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands-investigation of explanatory variables. Nephrol Dial Transplant 2012; 27: 803-809
32. Visser A, Sunaert P, Franssen CF et al. Exploration of the difference in incidence of renal replacement therapy in elderly patients in Flanders and The Netherlands-a comparison of referral policy. Nephrol Dial Transplant 2012; 27: 338-344
33. Judge A, Caskey FJ, Welton NJ et al. Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live? Nephrol Dial Transplant 2012; 27: 1598-1607
34. Gray NA, Dent H, McDonald SP. Renal replacement therapy in rural and urban Australia. Nephrol Dial Transplant 2012; 27: 2069-2076
35. Stewart JH, McCredie MR, Williams SM. Geographic, ethnic, age-related and temporal variation in the incidence of endstage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 2006; 21: 2178-2183
36. Stengel B, Billon S, Van Dijk PC et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003; 18: 1824-1833
37. Stel VS, van de Luijtgaarden MW, Wanner C et al. The 2008 ERA-EDTA Registry Annual Report-a precis. NDT Plus 2011; 4: 1-13